Omni Nutraceuticals
This article was originally published in The Tan Sheet
Executive Summary
Supplement maker's stock de-listed from the NASDAQ (symbol: ZONE) effective Nov. 17, Omni reports. Trading of shares was halted Nov. 7 following company's announcement it would restate previously reported financial results (1"The Tan Sheet" Nov. 13, In Brief). NASDAQ cites Omni's delay in filing amended 1999 10-K as one reason for delisting. Omni says it will appeal the action and anticipates filing amended 10-K and 10-Q reports shortly
You may also be interested in...
Omni Nutraceuticals
NASDAQ halts trading of Los Angeles-based supplement marketer's shares in response to SEC filing acknowledging need to restate financials, company explains Nov. 8. Exchange says stock will stay off market until Omni produces audited figures promised in Oct. 17 8-K filing
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands